Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion

被引:63
作者
Ayache, Saleh [1 ]
Panelli, Monica C. [1 ]
Byrne, Karen M. [1 ]
Slezak, Stefanie [1 ]
Leitman, Susan F. [1 ]
Marincola, Francesco M. [1 ]
Stroncek, David F. [1 ]
机构
[1] NIH, Dept Transfus Med, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA
关键词
D O I
10.1186/1479-5876-4-40
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The culture and expansion of human cells for clinical use requires the presence of human serum or plasma in culture media. Although these supplements have been extensively characterized in their chemical composition, only recently it has been possible to provide by high throughput protein analysis, a comprehensive profile of the soluble factors contributing to cell survival. This study analyzed and compared the presence of 100 proteins including chemokines, cytokines and soluble factors in six different types of media supplements: serum, plasma, recalcified plasma, heat inactivated serum, heat inactivated plasma and heat inactivated recalcified plasma. Methods: Serum, plasma, recalcified plasma, and heat inactivated supplements were prepared from ten healthy subjects. The levels of 100 soluble factors were measured in each sample using a multiplexed ELISA assay and compared by Eisen hierarchical clustering analysis. Results: A comparison of serum and plasma levels of soluble factors found that 2 were greater in plasma but 18 factors were greater in serum including 11 chemokines. The levels of only four factors differed between recalcified plasma and plasma. Heat inactivation had the greatest effect on soluble factors. Supervised Eisen hierarchical clustering indicated that the differences between heat inactivated supplements and those that were not were greater than the differences within these two groups. The levels of 36 factors differed between heat inactivated plasma and plasma. Thirty one of these factors had a lower concentration in heat inactivated plasma including 12 chemokines, 4 growth factors, 4 matrix metalloproteases, and 3 adhesion molecules. Heat inactivated decalcified plasma is often used in place of heat inactivated serum and the levels of 19 soluble factors differed between these two supplements. Conclusion: Our report provides a comprehensive protein profile of serum, plasma recalcified plasma, and heat inactivated supplements. This profile represents a qualitative and quantitative database that can aid in the selection of the appropriate blood derived supplement for human cell cultures with special requirements.
引用
收藏
页数:12
相关论文
共 19 条
[1]   Cytotoxic T lymphocyte therapy for Epstein-Barr virus Hodgkin's disease [J].
Bollard, CM ;
Aguilar, L ;
Straathof, KC ;
Gahn, B ;
Huls, MH ;
Rousseau, A ;
Sixbey, J ;
Gresik, MV ;
Carrum, G ;
Hudson, M ;
Dilloo, D ;
Gee, A ;
Brenner, MK ;
Rooney, CM ;
Heslop, HE .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (12) :1623-1633
[2]   Platelets synthesize large amounts of active plasminogen activator inhibitor 1 [J].
Brogren, H ;
Karlsson, L ;
Andersson, M ;
Wang, LW ;
Erlinge, D ;
Jern, S .
BLOOD, 2004, 104 (13) :3943-3948
[3]   In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines [J].
Bruserud, O ;
Glenjen, N ;
Ryningen, A ;
Ulvestad, E .
LEUKEMIA RESEARCH, 2003, 27 (05) :455-464
[4]   In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media:: Studies of native AML blasts and AML cell lines [J].
Bruserud, O ;
Gjertsen, BT ;
Von Volkman, HL .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (06) :923-932
[5]   Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy [J].
Einsele, H ;
Roosnek, E ;
Rufer, N ;
Sinzger, C ;
Riegler, S ;
Löffler, J ;
Grigoleit, U ;
Moris, A ;
Rammensee, HG ;
Kanz, L ;
Kleihauer, A ;
Frank, F ;
Jahn, G ;
Hebart, H .
BLOOD, 2002, 99 (11) :3916-3922
[6]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[7]   Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies [J].
Johnson, RT ;
Gibes, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1994-2004
[8]  
McNiece I, 2000, BLOOD, V96, P3001
[9]   Forecasting the cytokine storm following systematic interleukin (IL)-2 administration [J].
Panelli M.C. ;
White R. ;
Foster M. ;
Martin B. ;
Wang E. ;
Smith K. ;
Marincola F.M. .
Journal of Translational Medicine, 2 (1)
[10]   Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-Cell therapy [J].
Peggs, KS ;
Mackinnon, S .
HUMAN IMMUNOLOGY, 2004, 65 (05) :550-557